Data Sheet JADELLE - Medsafe
In the latter case, the woman should be advised to additionally use a barrier contraceptive method during the tablet-free interval or placebo tablet phase.
Download Data Sheet JADELLE - Medsafe
Information
Domain:
Source:
Link to this page:
Documents from same domain
ADVANTAN Presentation Uses - Medsafe
www.medsafe.govt.nzADVANTAN® Data Sheet Page 1 of 9 ADVANTAN® Methylprednisolone aceponate 0.1% ointment/cream . Presentation 1 g cream or ointment contains 1 mg (0.1%) methylprednisolone aceponate.
LOXALATE 1. Product Name - Medsafe Home Page
www.medsafe.govt.nzPage 5of 21 at risk, such as the elderly, or patients with cirrhosis, or if used in combination with other medications which may cause hyponatraemia.
DATA SHEET 1 CLEXANE AND CLEXANE FORTE ... - …
www.medsafe.govt.nzNew Zealand Data Sheet June 2017 . clexane-clexane-forte-ccdsv13-dsv18-16jun17 Page 2 . 100 mg injection enoxaparin sodium 100mg (equivalent to …
SEPTANEST Articaine hydrochloride 4% with …
www.medsafe.govt.nzSEPTANEST Articaine hydrochloride 4% with adrenaline 1:100,000 Injection for local and regional dental anaesthesia DESCRIPTION SEPTANEST is a sterile aqueous solution that contains articaine hydrochloride 4% (40 mg/mL) with adrenaline acid tartrate in a 1:100,000 strength.
BOOSTRIX - Medsafe Home Page
www.medsafe.govt.nz1 BOOSTRIX®. Combined diphtheria, tetanus, acellular pertussis (dTpa) vaccine . CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET? This leaflet answers some of the common questions about BOOSTRIX vaccine.
NEW ZEALAND DATA SHEET - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET Cymevene ® DS 170831 2 of 26 Caution: Cymevene must only be administered by IV infusion over 1 hour, preferably via a
Edition Draft - Medsafe
www.medsafe.govt.nzPart 4, Ed Draft Page 2 of 9 Section 1: Good Manufacturing Practice Documentation 1.1. When is GMP Documentation Required? Medsafe requires evidence of Good Manufacturing Practice (GMP) compliance for
Data Sheet 1 PRODUCT NAME 2 QUALITATIVE AND …
www.medsafe.govt.nzNew Zealand Data Sheet 31 July 2017 Lantus – insulin glargine lantus-ccdsv19-dsv11-31jul17 Page 1 Data Sheet 1 PRODUCT NAME Lantus 100 IU/mL solution for injection in 10 …
NEW ZEALAND DATA SHEET MESTINON® - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET MESTINON® MESTINON Page 4 of 8 As the severity of myasthenia gravis often fluctuates considerably, particular care is required to
DATA SHEET PREDNISONE - Medsafe
www.medsafe.govt.nz• Epilepsy and/or seizure disorder • Peptic ulceration • Previous steroid myopathy • Tuberculosis • Patients with myasthenia gravis receiving anticholinesterase therapy since
Related documents
BIRTH CONTROL METHOD COMPARISON CHART
ashasexualhealth.org© 2013 American Sexual Health Association Page 3 of 4 BIRTH CONTROL METHOD COMPARISON CHART (CONTINUED) METHOD EFFECTIVENESS AT PREVENTING PREGNANCY
SPECIALTY ALERTS CodingInstitute.com; SuperCoder.com ...
hcnewsletters.comDecember 2011, Vol. 14, No. 12 (Pages 81-88) 2011 Call us: 1-877-912-1691 The Coding Institute LLC, 2222 Sedwick Drive, Durham, NC 27713 Ob-Gyn Coding Alert Your practical adviser for ethically optimizing coding, payment, and efficiency in ob-gyn offices and clinics
Consumer Medicine Information - Medsafe
www.medsafe.govt.nz®Jadelle CMI 1 NEW ZEALAND CONSUMER MEDICINE INFORMATION . Jadelle®. levonorgestrel-releasing implant 75 mg x 2 . What is in this leaflet . Please read …
Contraceptive Pill Annual Checklist - The Castle Practice
www.thecastlepractice.nhs.ukContraceptive Pill Checklist In order to provide the contraceptive pill safely we need to ask you a number of questions. We would be grateful if you could complete this …
NEXPLANON (etonogestrel implant) - Merck.com
www.merck.comNEXPLANON (etonogestrel implant) Radiopaque Subdermal Use Only PATIENT CONSENT FORM I understand that there are many birth control methods and that each has its own benefits,risksand potential side effects.
HIGHLIGHTS OF PRESCRIBING INFORMATION ...
www.merck.com2 FULL PRESCRIBING INFORMATION 1 INDICATIONS AND USAGE NEXPLANON is indicated for use by women to prevent pregnancy. 2 DOSAGE AND ADMINISTRATION The efficacy of NEXPLANONdoes not depend on daily, weekly or monthly administration.